Advancing point-of-care technologies for global health challenges.
Official title: Technology Core
Funded at Cornell University · NIH-10928890 · Data updated 2026-11-12
This study is all about creating new, easy-to-use health tools that help with infections, cancer, and nutrition, and it's designed for healthcare providers who want to improve patient care in real-life situations.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cornell University NIH-funded |
| Lab location | 1 site (Ithaca, United States) |
| Project start | September 13, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $635,344 |
| NIH project number | 5U54EB034654-02 |
| Project ID | NIH-10928890 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals affected by infections, cancer, or nutritional issues who may benefit from innovative point-of-care technologies.
✕Less likely to help
Patients with conditions unrelated to infection, cancer, or nutrition may not receive direct benefits from this research.
What this research studies
This research focuses on developing and validating innovative point-of-care technologies that address critical health issues related to infection, cancer, and nutrition. The project involves collaboration with clinical partners and international stakeholders to identify and support promising technologies that can be deployed in real-world settings. By conducting annual needs assessments and fostering partnerships, the research aims to enhance the clinical viability of these technologies and facilitate their commercialization and training for project participants.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic and treatment options for patients facing infections, cancer, and nutritional deficiencies.
How similar studies have gone: Previous research has shown success in developing point-of-care technologies for similar health challenges, indicating a promising avenue for further exploration.
Where this research is happening
-
Cornell University
Ithaca, United States Active
Researchers
- Principal investigator: Erickson, David Carl — Cornell University
- Study coordinator: Erickson, David Carl
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.